Our data indicates RGZ and PGZ would be useful candidates to study the role of up-regulated PPARγ in prostate and bladder carcinoma as these ligands do not exhibit PPARγ-independent growth inhibitory effects. This evidence concerns the gene PPARG and urinary bladder carcinoma.